medical device investing Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse Vybrance Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules
medical device investing Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results
medical device investing Pulse Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference
medical device investing Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study
medical device investing Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026
medical device investing Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
medical device investing ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million
medical device investing Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
medical device investing Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results
medical device investing Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse Cardiac Catheter System at Heart Rhythm 2026
medical device investing Pulse Biosciences' nPulse Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
Equity Metals Announces a Significant Increase to the Mineral Resource Estimate at the Silver Queen Project, BC
Lahontan Consolidates Ownership of West Santa Fe, Eliminates Royalties, and Adds Strategic New York Canyon Project Through Acquisition of Emergent Metals
West High Yield Resources Receives Occupant Licence to Cut and Remove, Marking Another Major Regulatory Milestone at Record Ridge Magnesium Project
Metalsource Mining Extends High Grade Mineralization at Depth as Silver Hill Exploration Enters Major Expansion Phase
